Mainland Chinese technology and pharmaceutical companies are using Hong Kong as a launching pad for global expansion, industry leaders have said, as a major state-owned drugmaker weighs whether to invest in the city’s Northern Metropolis megaproject. The comments highlighting the city’s international background and professional expertise were made during a six-day trip to the rest of the Greater Bay Area, which was arranged by the Hong Kong and Macau Affairs Office and started on Sunday. “Hon...